There's a new pill for postpartum depression, but many at-risk women face hurdles • Stateline
$ 25.00 · 5 (631) · In stock
The first pill for postpartum depression approved by the U.S. Food and Drug Administration is now available, but experts worry that minority and low-income women, who are disproportionately affected by the condition, won’t have easy access to the new medication.
Emily Jankowski Newton on LinkedIn: #psi #impactreport #globalvoice #mission #pmhds #postpartum #pregnancy…
Health care Archives - Page 3 of 26 - Alabama Reflector
Postpartum depression: FDA approves fast-acting pill Zurzuvae
Zurzuvae: A Breakthrough for Postpartum Depression Treatment
Policy Center for Maternal Mental Health on LinkedIn
Pharmacist's worst fear: Mistakes at work
PlusIncUSA (@PlusIncUSA) / X
Nada Hassanein, Author at Rhode Island Current
PlusIncUSA (@PlusIncUSA) / X